Nikhil Kamath
Healthcare
General Catalyst leads $20 mn seed funding in Primus Senior Living
Primus Senior Living has raised $20 million (about Rs 168 crore) in seed funding, marking one of the largest early-stage ......
TMT
Nikhil Kamath's Gruhas invests in weavings; CloudKeeper buys WiseOps
Gruhas, a venture capital-style investment firm started by Zerodha co-founder Nikhil Kamath and entrepreneur Abhijeet Pai in 2021, has invested ......
TMT
Nazara Technology buys out promoters in Paper Boat, raises stake to 100%
Listed gaming firm Nazara Technology Friday said it has bought additional 48.42% stake in Paper Boat Apps Pvt Ltd, making ......
Infrastructure
Tiger Global-backed Infra.Market divests stake in subsidiary, nets $20 mn
Infra.Market, the business-to-business construction material marketplace last valued at $2.5 billion (Rs 20,872 crore), has divested part of its stake ......
General
Grapevine: Rare Rabbit taps more investors; Brookfield may back Leap Green
Rare Rabbit, a men's apparel brand, is closing its first institutional funding round of Rs 500 crore, led by investment ......
TMT
Zerodha's Nikhil Kamath, Kalaari Capital, NABVENTURES make startup bets
Speciality coffee brand Subko, real estate management platform Aeria, logistics startup JustDeliveries, footwear company Kaarigar Mandi and crypto platform Nomoex ......
Consumer
Hospitality chain Vro secures $10 mn in bridge round
Fine dining chain operator Vro Hospitality has raised $10 million (Rs 83 crore) in a bridge funding round, led by ......
Finance
Rainmatter's Dinesh Pai on its genesis and the logic of support over returns
Zerodha’s fintech, health and storytelling investment arm has covered quite a distance since its inception in 2016. With an aim to ......
Finance
Zerodha's FY23 profit growth slows; brokerage bullish on F&O vertical
India’s largest stock broking platform Zerodha saw slower growth in its bottomline as well as its topline for the financial ......
General
Grapevine: Dr Reddy's, Torrent eye M&As; True North racks up $78 mn for credit fund
Drugmaker Dr Reddy’s Laboratories has joined the fray with biopharmaceutical company Samsung Bioepis to take over US-based Biogen’s biosimilar business, a media report said. The ......
Recommended for you
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News